Small Business Innovation Research (SBIR) Small Business Technology Transfer (STTR)
spacer

SBIR/STTR News Flash Page

NIH CAP Deadline Extended to September 13, 2019!

August 26, 2019

Due to a few technical difficulties, and to accommodate new and/or incoming awardees, NIH is extending the deadline to apply to this groundbreaking NIH Commercialization Acceleration program (NIH CAP).

The new deadline is 11:59 p.m. PDT (Pacific) FRIDAY, September 13, 2019.

This is a cost free* customized commercialization (market readiness/growth) program.  For 16 years, CAP has provided customized technical/business assistance to companies at different stages, and has a notable track record: 50 acquisitions (including companies acquired by Sony, Zoll, Bruker, BioMarin, Illumina, Takeda, Google, Roche, etc.), 10 IPOsand more than $1B in 3rd party funding raised.

The program features:

  • world-class guidance from experienced domain professionals, including industry and technical specialists affiliated with Bayer Healthcare, Qualcomm, Baxter, Pfizer, Genetech, McKesson, Medtronic, CMS, Life Technology, etc.
  • Feedback and interaction from a range of stakeholders in the life sciences marketplace
  • Notable graduates of the CAP include: Sharklet and Lift Labs
  • Alumni benefit – Continued access to Larta's network and resources post program!

Given its long history of providing cutting-edge companies with cutting-edge assistance, NIH Program Managers are very involved and engaged with this program.

You don't have to wait for the deadline to apply. Reviews are being conducted now!

*CAP participation is free of charge for program participating companies; however, participants are responsible for travel and lodging expenses associated with attending workshops and program related events. 

For more details on this program, including success data, eligibility and instructions, please visit:
https://sbir.nih.gov/cap

NIH/CDC SBIR Contract Solicitation PHS 2020-1 Webinar Recording, Transcript, and Slides Now Available 

August 15, 2019

The NIH and CDC released the annual SBIR Contract Proposal Solicitation (PHS 2020-1) on July 10 and hosted a pre-proposal informational webinar on August 7 from 1PM to 3PM EDT.

The solicitation, electronic contract proposal submission (eCPS) website, clinical trials, iCorps at NIH, and specific topics with Program Managers from NCATS, NCI, NHLBI, NIAAA, NIAID, and CDC were addressed.

The slide presentationwebinar recording, and transcript are now available for your reference.

Webinar Slides

Recording

Transcript

(Please be advised, an automated transcription service was used, and there may be grammatical errors and typos in the transcript. We have done our best to correct as many errors as possible, but you are encouraged to reach out to us by email at sbir@od.nih.gov if anything remains unclear.)

The contract submission deadline is October 23, 2019, 5:00 PM EDT. Please follow the directions in the solicitation very carefully. You must respond exactly to a topic in the solicitation. As always, we encourage you to start the registration and application process early and reach out the central office or the funding Institute or Center of your choice for assistance.

Submission Process: There is an electronic submission process for all proposals. Applicants must use the Contract Proposal Submission (eCPS) website to submit their proposal. No other method of proposal submission is permitted. Instructions for electronic submission are provided in the solicitation.

Please check NOT-OD-19-121 for topics, contracting officer contact information and other details. You can also find the SBIR contract solicitation link on our Funding page and FedBizOpps.

Those interested in the PHS small business research GRANT programs, where investigator-initiated research ideas are encouraged, should use the Omnibus SBIR and STTR solicitations. You can find solicitation links on our Funding page. To understand better the differences between grants and contracts, view the Apply page.

 

Notice of Special Interest – SBIR/STTR FHIR Funding

August 13, 2019

The NIH is seeking innovative health IT solutions, implementing the Fast Healthcare Interoperability Resources (FHIR®) standard, to enable more effective patient-centered care coordination, population health management, and data science research support. (NOT-OD-19-127)

Grants and Administrative Supplements are now available to encourage awareness and interest among SBIR/STTR applicants and awardees in the areas of special interest related to the use of the FHIR standard in the development of health information technology (health IT) products and services. Health IT can improve health care quality and outcomes by enabling health care providers to effectively share information and apply evidence to support care decisions.

Several Federal health agencies are promoting the use of FHIR in EHR systems. The 21st Century Cures Act requires that a health information technology developer or entity “allow health information…to be accessed, exchanged, and used without special effort through the use of application programming interfaces (APIs)… including providing access to all data elements of a patient's electronic health record.” To implement this provision, the Department of Health and Human Services, Office of the National Coordinator for Health Information Technology (ONC) has proposed a new rule to support seamless and secure access, exchange, and use of electronic health information. Specifically, the proposed rule calls on the health care industry to adopt standardized APIs by using the FHIR standard to share patient data.

The NIH is issuing this Notice to highlight interest in receiving grant and administrative supplement applications focused on implementation of the FHIR standard in health IT applications including, but not limited to, the following area(s):

  • Integration of patient- and population-level data from EHR systems
  • Access to and management of electronic health information
  • Development of clinical decision support systems
  • Exchange of EHR data and health documentation
  • Enhancement of privacy and security for electronic health information
  • Inclusion of common data elements (CDEs) and clinical terminologies to improve interoperability of EHR data for research and clinical care
  • Support for a common structure for sharing clinical research data
  • Integration of EHR and patient-originated data with clinical research data
  • Design and monitoring of clinical trial protocols
  • Enhancement of patient recruitment, enrollment, and consent in clinical trials

The first available due date is September 5, 2019.

Read the complete Guide Notice here: NOT-OD-19-127

For information and instructions on how to apply, and to determine which FOA applies to you, click here.

All inquiries should be directed to:
Scientific/Research, Peer Review, and Financial/Grants Management contacts in Section VII of the listed funding opportunity announcements.

The NIH Commercialization Readiness Pilot (CRP) Program is back!

August 8, 2019

The newly re-authorized Commercialization Readiness Pilot (CRP) program is now accepting applications from previously or currently HHS-funded SBIR and STTR Phase II and Phase IIB awardees. Applications will be accepted from August 5, 2019 until April 6, 2022.

HHS can provide over $3 million in additional funding to facilitate the commercialization transition for projects, and support work that is not typically supported through SBIR/STTR Phase II or Phase IIB awards, including:

  • Preparation of documents for a Food and Drug Administration (FDA) submission
  • Development of an intellectual property strategy
  • Investigational New Drug (IND)-enabling studies
  • Clinical studies
  • Manufacturing costs
  • Regulatory assistance
  • Subcontracted work to other institutions, including contract research organizations (CRO)
  • A combination of services.

Although a significant amount of the work in a CRP award may be subcontracted to other institutions, the Small Business Concern (SBC) is expected to maintain oversight and management of the R&D throughout the award.

Please note, this re-authorization includes (3) separate Funding Opportunity Announcements (FOAs) with varying participating NIH Institutes and Centers:

  • PAR-19-333: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (Clinical Trial Not Allowed)
  • PAR-19-334: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (Clinical Trial Not Allowed)
  • PAR-19-335: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (Clinical Trial Required)

You can find the newly released Commercialization Readiness Pilot (CRP) Program solicitations on our HHS SBIR/STTR Funding page: https://sbir.nih.gov/funding#crp.

The CRP follows the Standard Due Dates (http://bit.ly/1MoGW3X), and the next deadline is on Thursday, September 5, 2019.

For questions about the Commercialization Readiness Pilot (CRP) Program at a participating institute, please find program officer contact information in Section VII of each solicitation.

For general and specific questions about the HHS SBIR/STTR programs, please contact sbir@od.nih.gov

The 2019-2020 NIH Commercialization Accelerator Program (CAP) is now OPEN! 

August 2, 2019

The 2019-2020 Commercialization Accelerator Program (CAP) is accepting applications until August 22, 2019.

Register for the Informational Webinar here: http://bit.ly/2yncvgP

If you are an SBIR/STTR Phase II Awardee with interest and questions regarding the NIH CAP, please register for the Information Session Webinar which will be held on Thursday, August 8, 2019 from 12:30pm-2:00pm EDT, as Rohit Shukla, CEO of Larta Institute, and JP Kim, SBIR-STTR Program Manager at NIH, host an informational webinar on the NIH Commercialization Accelerator Program (CAP).

This program is designed to assist HHS SBIR/STTR Phase II awardees in evaluating their commercialization options based on their specific technologies (including the need and prospect for investment, strategic partnerships, or licensing), and help them develop a solid market-entry plan covering an 18-month period.

CAP is customized to meet the needs of participating companies in three distinct tracks:

  • The Commercialization Transition Track (CTT) for emerging companies
  • The Advanced Commercialization Track (ACT) and
  • The Regulatory/Reimbursement Training Track (RTT) for “seasoned” companies

There are eighty (80) available slots that will be distributed throughout these tracks.

Questions about the CAP?

Please direct all inquiries to:

J.P. Kim, J.D., M.B.A., M.P.P., M.Sc., M.A.
National Institutes of Health (NIH)
Telephone: 301-435-0189
Email: sbir@od.nih.gov

NIGMS Seeking Methods to Improve Reproducibility of Human iPSC Derivation, Growth and Differentiation – SBIR Phase II Applicants ONLY

July 16, 2019

The National Institute of General Medical Sciences (NIGMS) is seeking Small Business Innovation Research (SBIR) Phase II applications to develop methods that improve the reproducibility of human induced pluripotent stem cell (iPSC) derivation, growth, and differentiation (RFA-GM-19-001).

As you may know, realizing the full potential of human iPSCs for both research and clinical practice has been limited by the significant variability in reprogramming efficiency, differentiation potential, and cell growth and stability. This Funding Opportunity Announcement (FOA) will support SBIR projects to develop novel, reliable and cost-effective methods to standardize and increase the utility and reproducibility of iPSCs at all stages, from their derivation to their research and clinical applications.

Human induced pluripotent stem cells (iPSCs) have been used with great success to mimic the differentiation of a variety of tissues, understand early development and study human diseases. Despite approaches that have made the derivation, growth and differentiation of iPSCs more efficient, there remains significant variability in reprogramming efficacy, genomic integrity and developmental potential of iPSCs derived from a single fibroblast or tissue sample. Thus, iPSCs derived from the same sample may differ in their in vitro growth characteristics and their ability to re-differentiate into the desired tissue type. A variety of issues may affect derivation of the iPSCs and their growth, stability and differentiation, including the specific characteristics of the starting cell or tissue sample (e.g., age of donor, tissue type and anatomical location, physiological and disease state), the methods and protocols used to induce pluripotency (e.g., transcription factors, small molecules, cell fusion), the choice of growth factors and other culture conditions, method of storage of cell lines, etc. Further challenges include growing and maintaining sufficient quantities of iPSC lines in culture without changes in their properties, as well as the ability of multiple investigators to identify and authenticate iPSC lines as part of their research.

The following NIH Institutes and Centers intend to commit funds, with an estimated 25 awards:

National Institute of General Medical Sciences (NIGMS)

National Cancer Institute (NCI)

National Heart, Lung, and Blood Institute (NHLBI)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute on Drug Abuse (NIDA)

National Institute of Environmental Health Sciences (NIEHS)

National Center for Advancing Translational Sciences (NCATS)

We hope this broad reach will help us develop novel, reliable, and cost-effective methods to standardize and increase the utility and reproducibility of iPSCs at all stages, from their derivation to their research and clinical uses. Applications will be accepted from December 6, 2019 through January 6, 2020.

For questions, please use the Institute/Center’s Scientific/Research Contact(s) located in Section VII of the FOA:

https://grants.nih.gov/grants/guide/rfa-files/RFA-GM-19-001.html

 

NIH/CDC PHS 2020-1 Contract Solicitation Now Available!

July 10, 2019

Register for the Informational Webinar! 

The NIH and CDC have released the annual SBIR Contract Proposal Solicitation (PHS 2020-1), with a submission date of October 23, 2019, 5:00 PM EDT. Please follow the directions in the solicitation very carefully. You must respond exactly to a topic in the solicitation.

We will conduct a pre-proposal conference, via webinar, on August 7 at 1:00 PM EDT. This informational webinar will discuss the PHS 2020-1 solicitation, electronic contract proposal submission (eCPS) website, clinical trials, and topics. 

Please register for HHS SBIR PHS 2020-1 Contract Webinar in advance, here:
https://attendee.gotowebinar.com/register/7505039171902241027

(After registering, you will receive a confirmation email containing information about joining the webinar.)

The following Institutes/Centers have issued research topics in the PHS 2020-1 Solicitation:

National Institutes of Health (NIH)

  • National Center for Advancing Translational Sciences (NCATS)
  • National Cancer Institute (NCI)
    National Heart, Lung and Blood Institute (NHLBI)
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  • National Institute of Allergy and Infectious Diseases (NIAID)

Centers for Disease Control and Prevention (CDC)

  • National Center for Chronic Disease and Health Promotion (NCCDPHP)
  • National Center for Environmental Health (NCEH)
  • National Center for Emerging Zoonotic and Infectious Diseases (NCEZID)
  • National Center for Immunization and Respiratory Diseases (NCIRD)
     

Submission Process: 
There is an electronic submission process for all proposals. Applicants must use the Contract Proposal Submission (eCPS) website to submit their proposal. No other method of proposal submission is permitted. Instructions for electronic submission are provided in the solicitation.

Please check NOT-OD-19-121 for topics, contracting officer contact information and other details. You can also find the SBIR contract solicitation link on our Funding page and FedBizOpps.

Those interested in the PHS small business research GRANT programs, where investigator-initiated research ideas are encouraged, should use the Omnibus SBIR and STTR solicitations. You can find solicitation links on our Funding page. To understand better the differences between grants and contracts, view the Apply page.

 

HHS SBIR/STTR PHS 2019-2 Grant Omnibus Webinar Recording, Transcript, and Slides Now Available

June 7, 2019

On May 29, 2019 at 1:00 PM EDT, the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Program hosted a webinar to assist interested applicants with understanding proposal preparation, federal guidelines and resources, the funding process, and address general concerns.

The webinar presentation, recording, and transcript are now available for your reference. (Please be advised, an automated transcription service was used, and there may be grammatical errors and typos in the transcript.) We have done our best to correct as many errors as possible, but you are encouraged to reach out to us by email at sbir@od.nih.gov if anything remains unclear.

Webinar Slides

Recording

Transcript

HHS SBIR and STTR Omnibus grant solicitations permit researcher-initiated topics around health, medicine and life science to be submitted for funding consideration. With any specific idea, you should speak directly with a HHS SBIR/STTR program manager at least a month BEFORE the deadline to gauge their interest.

You can find the HHS SBIR/STTR Omnibus Solicitations, and all of our other SBIR/STTR solicitations on the Funding page of our website:  https://sbir.nih.gov/funding. Be sure to also check the targeted funding announcements page, https://sbir.nih.gov/funding/individual-announcements. NIH Institutes and Centers will issue targeted SBIR/STTR grant solicitations around specific, high-priority research areas.

The next submission deadline is September 5, 2019.

 

Reminder: 2019 HHS SBIR/STTR PHS 2019-2 Grant Omnibus Informational Webinar

May 24, 2019

Interested in applying for biotech funding for your small business, but not sure where to start? Register for this informational webinar on Wednesday, May 29 @ 1PM-3PM:
http://bit.ly/2wl43NO

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Program will host a webinar to assist interested applicants with understanding proposal preparation, federal guidelines and resources, the funding process, and other general concerns.

The HHS SBIR and STTR Omnibus grant solicitations permit researcher-initiated topics around health, medicine and life science to be submitted for funding consideration. With any specific idea, you should speak directly with a HHS SBIR/STTR program manager at least a month BEFORE the deadline to gauge their interest.

NIH Matchmaker can be used to conduct keyword searches of a particular topic area to identify NIH Institutes or Centers (ICs) that have previously funded research in that area. Applicants can also search the 2019 Program Descriptions and Research Topics document to identify priority research areas of ICs, or email sbir@od.nih.gov for an SBIR/STTR program manager referral. 

Dr. Matthew Portnoy, NIH SBIR/STTR Program Manager, Office of Extramural Programs at the National Institutes of Health will cover:

  • SBIR 101
  • 2019 SBIR/STTR Omnibus Grant Solicitations for the NIH, CDC, and FDA
  • 2019 Deadlines
  • Reauthorizations
  • Live Questions + More!

You can find the HHS SBIR/STTR Omnibus Solicitations, and all of our other SBIR/STTR solicitations on the Funding page of our website:  https://sbir.nih.gov/funding. Be sure to also check the targeted funding announcements page, https://sbir.nih.gov/funding/individual-announcements. NIH Institutes and Centers will issue targeted SBIR/STTR grant solicitations around specific, high-priority research areas.

An informational webinar will occur on Wednesday, May 29, 2019 at 1:00 PM to 3:00 PM EDT. We welcome you to submit questions ahead of time through the registration link below, these questions will also be addressed during the webinar. 

Please register for the HHS SBIR/STTR PHS 2019-2 Grant Omnibus Webinar on May 29, 2019 at 1:00 PM EDT: http://bit.ly/2wl43NO

After registering, you will receive a confirmation email containing information about joining the webinar.

SBIR Phase II Funding Opportunity at NIDILRR/ACL

May 13, 2019

The National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), (Administration for Community Living (ACL) has released the solicitation for an SBIR Phase II funding opportunity. The specific purpose of NIDILRR's SBIR program is to increase the commercial application of research and development results and improve the return on investment from research and development that can be used to improve the lives of individuals with disabilities. All SBIR projects funded by NIDILRR must address the needs of individuals with disabilities and promote their health and function, community living, or employment outcomes. 

Review the Grant Opportunity here:
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313440

Eligible Applicants:
SBIR Phase I grantees who received their Phase I grant in fiscal year 2017 or 2018 are eligible to apply.

These eligible applicants only include:

(1) Phase I grantees who received their FY 2017 or FY 2018 Phase I funding from NIDILRR, or
(2) Phase I grantees with FY 2017 or FY 2018 Phase I funding from another agency to conduct projects that aim to improve the lives of people with disabilities.
Applicants must also continue to be small business concerns.

Total Amount:  $575,000 per award
Applications due:  July 1, 2019 by 11:59PM Local Time

An Informational Conference Call will be held to discuss this solicitation on Tuesday, May 28, 2019 at 3:00 PM EDT. You may join the call on the given date and time by WebEx or phone using the information below:

WebEx: Join the meeting
Meeting Number: 998 077 999
Audio Information: (202) 774-2300
Access Code: 998 077 999

For questions, please contact:
Brian Bard, Program Specialist
National Institute on Disability, Independent Living, and Rehabilitation Research
Administration for Community Living
brian.bard@acl.hhs.gov

2019 HHS SBIR and STTR Omnibus Grant Solicitations Now Available

May 8, 2019

The next deadline is September 5, 2019.

The Department of Health and Human Services (HHS) has just released the 2019 Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Omnibus Grant Solicitations! These solicitations will be used by the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA). Note STTR is only available at NIH. You can read more in NOT-OD-19-105: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-105.html

The HHS SBIR and STTR Omnibus grant solicitations permit researcher-initiated topics around health, medicine and life science to be submitted for funding consideration. With any specific idea, you should speak directly with a HHS SBIR/STTR program manager at least a month BEFORE the deadline to gauge their interest.

NIH Matchmaker can be used to conduct keyword searches of a particular topic area to identify NIH Institutes or Centers (ICs) that have previously funded research in that area. Applicants can also search the 2019 Program Descriptions and Research Topics document to identify priority research areas of ICs, or email sbir@od.nih.gov for an SBIR/STTR program manager referral. 

The 2019 SBIR/STTR Omnibus solicitations and accompanying resources can be found below:

  • PA-19-272 - PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed
  • PA-19-273 - PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required
  • PA-19-270 - PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed
  • PA-19-271 - PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required

Standard Application Due Dates: September 5, 2019, January 6, 2020, and April 6, 2020 (since January and April 5, 2020 fall on a Sunday)

An informational webinar will occur on Wednesday, May 29, 2019 at 1:00 PM to 3:00 PM EDT. Please register for the HHS SBIR/STTR PHS 2019-2 Grant Omnibus Webinar on May 29, 2019 at 1:00 PM EDT: 

https://attendee.gotowebinar.com/register/483596398390515457

After registering, you will receive a confirmation email containing information about joining the webinar.

You can find the HHS SBIR/STTR Omnibus Solicitations, and all of our other SBIR/STTR solicitations on the Funding page of our website:  https://sbir.nih.gov/funding. Be sure to also check the targeted funding announcements page, https://sbir.nih.gov/funding/individual-announcements. NIH Institutes and Centers will issue targeted SBIR/STTR grant solicitations around specific, high-priority research areas.

Get Free SBIR/STTR Application Support from NCI SBIR!

May 6, 2019

The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center is pleased to announce the availability of the 2019 Applicant Assistance Program (AAP). AAP is a FREE program for small businesses that have not previously received an SBIR/STTR award from the National Institutes of Health. The program provides small businesses with services including:

  • Needs assessment
  • Small business mentoring
  • Phase I SBIR/STTR application preparation support
  • Application review
 

If you are interested in participating in AAP, join us for an informational webinar on Thursday, May 9, 2019, 1-2 p.m. EDT. Topics to be covered include:

  • SBIR/STTR program basics
  • Eligibility criteria
  • AAP Information
  • How to write an application for AAP

Click here to sign up for the webinar.

The pilot AAP is only available for small businesses with cancer-related projects. AAP provides application coaching—participating small businesses will still be responsible for putting together an application and other required documentation. To apply for the program, please visit http://bit.ly/19AAP.

One of the goals of AAP is to increase participation in the SBIR/STTR program by businesses that are owned or controlled by individuals who are traditionally underrepresented in the biomedical sciences. Therefore, NIH is particularly interested in applications from socially/economically disadvantaged small businesses (SDB), women-owned small business (WOSB), and small businesses located in under-represented states.

For questions on the program, please contact NCI SBIR Program Director Kory Hallett (kory.hallett@nih.gov) or Christie Canaria (christie.canaria@nih.gov).

2019 SBIR Road Tour will stretch from Arizona to Vermont

April 16, 2019

First stop is Oklahoma City, OK! Register for the SBIR Workshop in your city today.

The U.S. Small Business Administration (SBA) announced it will launch a 16-stop road tour connecting entrepreneurs working on advanced technology to the country’s largest source of early stage funding – the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. Also known as America’s Seed Fund, the SBIR/STTR programs focus on next generation research & development (R&D) and is led by the SBA with 11 participating federal agencies.

“Every year, we meet entrepreneurs from around the country looking to turn their big idea into another great American innovation story.  We are committed to supporting America’s small businesses owners wherever they are,” SBA Administrator Linda McMahon said.  “This tour reflects our continued commitment to ensuring that these innovators are aware of SBA’s resources to help them reach that goal.” 

The SBIR Road Tour plays an important role in increasing engagement with entrepreneurial ecosystems across the country and building out greater networks to support the creation of small businesses focusing on high-impact research. 

Each SBIR Road Tour stop will be hosted by a local organization involved in supporting entrepreneurs in next generation R&D.  Program managers from the participating federal agencies will conduct one-on-one meetings with attendees, take part in targeted panels, discuss technology areas, and share insights into how the agencies make funding decisions. Register for your city here!

The SBIR/STTR programs provide over $3 billion in early stage funding to small businesses each year in a wide variety of technology areas such as unmanned systems, advanced materials, health, cybersecurity and defense.  The SBIR/STTR programs execute over 4,000 new awards annually, which allow innovators to advance new technologies and have contributed to the creation of thousands of jobs.

Tour Dates + Locations:

May 20-24 | Central Plains Tour

  • Oklahoma City, OK
  • Kansas City, KS
  • Des Moines, IA
  • Sioux Falls, SD
  • Fargo, ND

August 12-16 |Southwest Tour

  • Tucson, AZ
  • El Paso, TX
  • Albuquerque, NM
  • Boulder, CO

September 16-20 | Eastern Tour

  • Burlington, VT
  • Albany, NY
  • New Brunswick, NJ
  • State College, PA
  • College Park, MD

November 13-15 | Miami, FL and Puerto Rico
More on the tour, how to join us, and how to bring SBIR and STTR resources to your small business community here: http://www.sbirroadtour.com/

 

Last Chance! Register for the 2019 NIH Regional Seminar in Baltimore, MD

March 29, 2019

Demystify the grants application and review process
Registration prices increase on March 30, register today!
Where: Renaissance Baltimore Harborplace Hotel
When: May 15-17, 2019

Whether you are an administrator, early stage investigator, researcher, or graduate student — there is something to learn for everyone!

The NIH Regional Seminar serves the NIH mission of providing education and training for the next generation of biomedical and behavioral scientists. This seminar is intended to:

  • Demystify the application and review process
  • Clarify federal regulations and policies
  • Highlight current areas of special interest or concern

Who Should Attend? The seminar and optional workshops are appropriate for those who are new to working with the NIH grants process – administrators, early stage investigators, researchers, graduate students, etc. For those with more experience, the seminar offers a few more advanced sessions, updates on policies and processes direct from NIH staff, as well as valuable presentation resources to share with your institution.

Who are the Presenters? The NIH Regional Seminar involves approximately 65 NIH and HHS staff who are brought to a central location in order to educate, share, and hear your questions over the course of two days, plus the pre-seminar workshops.

This seminar is your opportunity to make direct contact with NIH policy officials, grants management, program and review staff, and representatives from the HHS Office for Human Research Protections (OHRP), HHS Office of the Inspector General (OIG), and others. In addition, take advantage of discussions involving more than 600 fellow attendees from around the world.

In addition to learning more about the NIH grants processes and policies through the optional workshops and 2-day sessions, there are opportunities throughout the seminar to Meet the Experts 1:1. These 15 minutes chats are a great way to get more specific questions answered by NIH & HHS experts.  You’ll have the opportunity to sign up in advance or on-site to speak with the expert(s) of your choice participating in the seminar.

Over 25 topics being covered during this 2-day event, including:

  • Grant Writing for Success
  • Career Development
  • Diversity in the Extramural Research Workplace
  • Peer Review and Compliance
  • Loan Repayment Program
  • Animals and Humans in Research and much more!

The room block is now SOLD OUT, click here for the list of alternative hotels and transportation options!

View the agenda and learn more about the 2019 NIH Regional Seminar.

2019 Multi-IC SBIR/STTR Small Business Workshop

March 19, 2019

The National Institute of Allergy and Infectious Diseases (NIAID) is hosting a Small Business Workshop for SBIR/STTR stakeholders on May 15-16, 2019 at the California NanoSystems Institute at the University of California, Los Angeles. Register here.
 

The purpose of this workshop is to prepare current and next-generation biomedical entrepreneurs to compete in NIAID's (and other Federal) SBIR/STTR programs, and survey other resources for technology commercialization. Biotechnology entrepreneurs, new faculty, post-doctoral fellows, and all other innovators who are interested in starting new biomedical enterprises are encouraged to attend.

Attendees will learn about career opportunities in biomedical entrepreneurship that are supported by the NIH, receive guidance for preparation of successful grant applications, and be updated on current NIH SBIR/STTR policies and regulations. We will also discuss SBIR/STTR opportunities for women-owned and socially and economically disadvantaged small businesses.

The NIAID-led Program will include the NIH SBIR/STTR Program Office, Center for Scientific Review (CSR) and National Institute of Biomedical Imaging and Bioengineering (NIBIB). Additionally, we’ll be joined by other SBIR/STTR Agencies including the National Science Foundation (NSF) and Centers for Disease Control and Prevention (CDC).

The agenda will include:

  • An overview of the NIH SBIR/STTR programs
  • Introductions to programs administered by NIAID
  • Application review, Award Management, Venture Capital and other sources of Investment
  • SBIR/STTR grant/proposal writing
  • Panel discussions and One-on-One sessions with NIH Funding

View the Full Agenda

Register today!

For more information, please contact:
Natalia Kruchinin Ph.D.
NIAID SBIR/STTR Program Coordinator
RTSP, DEA, National Institute of Allergy and Infectious Diseases, NIH
Phone (240) 669-2919
kruchininn@niaid.nih.gov

Announcing the InVision Tour — For Minority Innovators and Industrialists

February 28, 2019

Join us on March 21-22 in Houston, TX | Register TODAY!
Discover how you can imagine, invent, and incorporate your own products with federal resources and build wealth for your company, community, and the country.

The Invision Tour

We are thrilled to announce that the NIH SBIR/STTR Program will be joining the InVIsion Tour for remaining dates in Houston, TX; Oakland, CA; New York, NY; and Detroit, MI.

See what the audience experienced at the first stop in Atlanta, GA!

The InVision Tour is a national effort of the Minority Business Development Agency (MBDA) to increase the participation of minority business enterprises and minority-serving institutions in Technology Transfer (T2) and Small Business Innovation Research (SBIR).

The mission of this tour is to inform U.S. minorities about the benefits of federal resources and expand opportunities to develop solutions and products of the future. Through federal government collaboration, minority entrepreneurs, scientists, engineers, pioneers, thinkers, inventors, and visionaries can learn about technology transfer and how public R&D access can lead to building wealth for their company, community, and the country.

InVision gives you access to valuable professional contacts from around the U.S. and all the knowledge you need to get started in T2:

  • 10+ peer-selected presentations. Covering partner strategies to financing, and everything in between.
  • 10+ local labs in one place, at one time. See what innovations you could be using to commercialize.
  • 200+ professionals and entrepreneurs. Network and build essential partnerships.

This tour is for you if...

  • you currently have an idea or invention that you want to bring to market,
  • you have the infrastructure and resources to fund a new innovative invention,
  • you need access to R&D labs, human capital, facility space, patent attorneys, access to ideas, and more!

The next stop will be in Houston, TX at the TMC Innovation Institute, March 21-22. Register now!

Follow the tour on Facebook, Twitter, Instagram, and LinkedIn.

New NIH SBIR Podcast – All About Diversity

February 15, 2019

In this next installment of the "All About Grants" podcast series, small business innovators can learn more about programs geared towards women-owned companies or those led by socially or economically disadvantaged groups. Listen here | Transcript.

Dr. Kory Hallett, a Program Director with the National Cancer Institute, and Ms. Stephanie Fertig, a Director of Small Business Programs with the National Institute of Neurological Disorders and Stroke, will highlight how NIH is taking steps towards diversifying the NIH small business programs. You will hear about who qualifies, tips for strengthening your application, and what goes on behind-the-scenes in a study section reviewing the merit of your application. They also share some good general food-for-thought that many other applicants may find helpful when trying to turn research ideas into words.

More podcasts are available on the All About Grants podcast page.

NIH Research Evaluation and Commercialization Hub (REACH) Program

February 11, 2019

On January 23, 2019, the National Institutes of Health hosted a free pre-submission webinar to discuss the renewal of the NIH Research Evaluation and Commercialization Hub (REACH) program.

Read the Funding Opportunity Announcement (RFA-OD-19-014) here.

The webinar video recording, slides, and transcripts are available below:

REACH Pre-Submission Webinar Recording

REACH Pre-Submission Webinar Slides

Transcript – REACH Pre-Submission Webinar

Transcript – REACH Webinar Questions & Answers Session

Through this program, NIH will provide the qualifying institutions with funds to seed the creation of academic entrepreneurship Hubs. Hubs will be responsible for providing innovators with both the initial investment and resources to support the proof of concept work and the mentorship in product development and commercialization needed to develop high priority technologies that address the highest US disease burden within the NIH’s mission.

Apply here!

All applications are due March 19, 2019 by 5:00 PM Local Time. Applicants are strongly encouraged to contact the appropriate NIH Scientific/Research contact listed in Section VII of RFA-OD-19-014.

NIH Research Evaluation and Commercialization Hub (REACH) Awards + Webinar

January 22, 2019

We are pleased to announce the renewal of the NIH Research Evaluation and Commercialization Hub (REACH) program, established to facilitate and accelerate the translation of academic biomedical discoveries into products that improve patient care and public health.

Read the Funding Opportunity Announcement (RFA-OD-19-014) here.

Register for the informational webinar: https://bit.ly/2RMsald

Through this program, NIH will provide the qualifying institutions with funds to seed the creation of academic entrepreneurship Hubs. Hubs will be responsible for providing innovators with both the initial investment and resources to support the proof of concept work and the mentorship in product development and commercialization needed to develop high priority technologies that address the highest US disease burden within the NIH’s mission.

Funded Hubs are intended to work as a consortium to enable: (1) the infrastructure for identifying the most promising technologies, (2) funding for product definition studies (e.g. feasibility studies, prototype development, proof-of-concept studies) provided to individual researchers, (3) access to expertise in areas required for early stage technology development (including scientific, regulatory, reimbursement, business, legal, and project management), and (4) skills development and hands-on experience in entrepreneurship. 

All applications are due March 19, 2019 by 5:00 PM Local Time. Applicants are strongly encouraged to contact the appropriate NIH Scientific/Research contact listed in Section VII of RFA-OD-19-014.

A free pre-submission webinar will be held on January 23, 2019 at 1pm ET; please register here: https://bit.ly/2RMsald

 

Join Entrepreneurship Experts for I-Corps at NIH Webinar

January 17, 2019

Join Entrepreneurship Experts for I-Corps at NIH Webinar

I-Corps at NIH is an entrepreneurship training program designed specifically for small businesses in biomedical industries. Eligibility is limited to companies with active Phase I SBIR or STTR award from any of the 22 participating NIH and CDC institutes and centers. To be considered for the April 2019 cohort, submit your application by Monday, January 28, 2019, 5 p.m. local time.

To learn more about the program, sign up for a free-form online Q&A Session on Tuesday, January 22, 2019, 2 to 3 p.m. Eastern Standard Time. This will be a free-form session where you can submit questions regarding the details of the program and the application processes. I-Corps at NIH Program Manager Christie Canaria will be available to provide program and eligibility information, as well as answers to your questions.

[Register here]

For questions about the webinar or the I-Corps at NIH program, please contact icorps@mail.nih.gov.

Last Chance! Only a few slots remaining for the 2018-2019 Niche Assessment Program 

January 14, 2019

Are you an SBIR/STTR Phase I Awardee looking for tailored market research for your technology? Apply for the Niche Assessment Program today!

Designed to help small businesses strategically position their technology in the marketplace, the Niche Assessment Program provides an in-depth report on potential applications of participants’ technology. All active HHS (NIH, CDC, and FDA) SBIR/STTR Phase I awardees and Phase I Fast-Track awardees (by grant or contract) are eligible to apply. Applications are accepted on a rolling basis until all slots are filled. The next cohort will begin in early October 2019.

Niche provides market insight and data that can be used to help small businesses strategically position their technology in the marketplace. The results of this program can help small businesses develop their commercialization plan for their Phase II application, and be exposed to potential partners. Services are provided by Foresight Science & Technology of Providence, RI.

Technology Niche Analyses® (TNA®) are provided by Foresight, for two hundred (200), HHS SBIR/STTR Phase I awardees. These analyses assess potential applications for a technology and then for one viable application, it provides an assessment of the:

  1. Needs and concerns of end-users;
  2. Competing technologies and competing products;
  3. Competitive advantage of the SBIR/STTR-developed technology;
  4. Market size and potential market share (may include national and/or global markets);
  5. Barriers to market entry (may include, but is not limited to pricing, competition, government regulations, manufacturing challenges, capital requirements, etc.);
  6. Market drivers;
  7. Status of market and industry trends;
  8. Potential customers, licensees, investors, or other commercialization partners; and,
  9. The price customers are likely to pay.

Each participant receives an in-depth report of Foresight's findings. The small business can often use this information in their commercialization plan, which is part of their Phase II SBIR/STTR application.

For more information, see Notice NOT-OD-19-012 that was issued in the NIH Guide for Grants and Contracts on October 4, 2018.

To participate in the program, apply here.

Inquiries:

For assistance regarding the online set-up form, please contact:
Ms. Paula Williams
Project Coordinator
Foresight Science & Technology
Telephone: (401) 273-4844, ext. 4001
Fax:  (401) 354-1301
Email:  Paula.Williams@foresightst.com

Specific questions about TNA's may be directed to:
Konstantin Izvolsky, PhD.
Director of Assessments and Training
Foresight Science & Technology
Telephone: (401) 273-4844, ext. 4003
Email:  konstantin.izvolsky@foresightst.com

General questions about Niche Assessment Program may be directed to:
Robert Vinson 
Program Manager
NIH SBIR/STTR Program
Office of Extramural Research
Phone: (301) 435-2713
Email:  sbir@od.nih.gov

 

News Archives:

archive icon  These web pages are archived & provided for historical reference purposes only. The content and links are no longer maintained and may be outdated.